4 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp02225 | CA-MA | KWKLFKKIGIGKFLHSAKKF | Ceropin-Melittin hybrid | Membrane disruptive mode of action | MTT/MTS assay | Calu-6 | Lung cancer | Activity : ~90% survival rate at 10 µM |
| dbacp02226 | CA-MA | KWKLFKKIGIGKFLHSAKKF | Ceropin-Melittin hybrid | Membrane disruptive mode of action | MTT/MTS assay | Calu-6 | Lung cancer | Activity : <20% survival rate at 100 µM |
| dbacp06177 | Synthetic peptide | KWKKLLKKPPPLLKKLLKKL | Synthetic peptide | Not specified | MTT/MTS assay | Calu-6 | Lung cancer | 35% survival rate at 10 µM |
| dbacp06178 | Synthetic peptide | KWKKLLKKPPPLLKKLLKKL | Synthetic peptide | Not specified | MTT/MTS assay | Calu-6 | Lung cancer | 0% survival rate at 100 µM |